News

Since 2001, Dr Werner has been a managing director and senior vice president of GlaxoSmithKline (GSK) and has served as CEO of the GSK Foundation until earlier this

Most recently, Mr DuFresne served as president and CEO of Pacgen Biopharmaceuticals. Prior to that, Mr DuFresne served as president and CEO of Zelos Therapeutics and ConjuChem and

The company has also appointed Mr Gallitano to serve on the compensation, nominating and corporate governance, and healthcare quality and access committees of the board. Mr Gallitano has

Osi Pharmaceuticals, a biotechnology company, and Genentech, have announced that Osi has submitted a supplemental new drug application to the FDA for the use of Tarceva as a

Financial Highlights: Increased sales of $1.0 million in our infectious disease product lines were partially offset by a decrease of $0.5 million in sales of Eclectica” as a

Ferring Pharmaceuticals, a specialty biopharmaceutical company, has launched Firmagon, a new treatment option in hormonal therapy for prostate cancer, in Europe. The European launch of Firmagon follows the

Takeda Pharmaceutical Company has filed a new drug application to the Ministry of Health, Labour and Welfare for Lampion for treatment of secondary eradication of Helicobacter pylori. According

Under the agreement, American CareSource will make available its full complement of ancillary care services to InterGroup’s clients through a network of ancillary care providers. American CareSource expects

For the fiscal year 2008, the company reported a net loss of E21.28 million or E0.58 per share, a decrease of 71%, compared to a net loss of